$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells

Blood, v.96 no.10, 2000년, pp.3302 - 3309  

Palumbo, Joseph S. (From the Divisions of Hematology) ,  Kombrinck, Keith W. (From the Divisions of Hematology) ,  Drew, Angela F. (From the Divisions of Hematology) ,  Grimes, Timothy S. (From the Divisions of Hematology) ,  Kiser, John H. (From the Divisions of Hematology) ,  Degen, Jay L. (From the Divisions of Hematology) ,  Bugge, Thomas H.

Abstract AI-Helper 아이콘AI-Helper

Detailed studies of tumor cell-associated procoagulants and fibrinolytic factors have implied that local thrombin generation and fibrin deposition and dissolution may be important in tumor growth and dissemination. To directly determine whether fibrin(ogen) or plasmin(ogen) are determinants of the m...

참고문헌 (54)

  1. Thromb Haemost. Costantini 69 406 1993 10.1055/s-0038-1651624 Fibrin and cancer. 

  2. Thromb Haemost. Donati 74 278 1995 10.1055/s-0038-1642690 Cancer and thrombosis: from Phlegmasia alba dolens to transgenic mice. 

  3. Hum Pathol. Dvorak 18 275 1987 10.1016/S0046-8177(87)80010-2 Thrombosis and cancer. 

  4. Ann N Y Acad Sci. Dvorak 667 101 1992 10.1111/j.1749-6632.1992.tb51603.x Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. 

  5. Haemostasis. Cavanaugh 18 37 1988 Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis. 

  6. Cancer Res. Esumi 51 4549 1991 Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. 

  7. J Clin Invest. Mueller 101 1372 1998 10.1172/JCI930 Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. 

  8. Invasion Metastasis. Walz 14 303 1994 The role of thrombin in tumor cell metastasis. 

  9. Blood Coagul Fibrinolysis. Bardos 7 536 1996 10.1097/00001721-199607000-00005 Fibrin deposition in primary and metastatic human brain tumours. 

  10. N Engl J Med. Dvorak 315 1650 1986 10.1056/NEJM198612253152606 Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. 

  11. Am J Pathol. Harris 108 119 1982 Fibrin deposits in Hodgkin's disease. 

  12. Am J Pathol. Brown 130 455 1988 Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma. 

  13. Cancer Res. Dvorak 44 3348 1984 Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas. 

  14. J Clin Invest. Altieri 78 968 1986 10.1172/JCI112687 Binding of fibrinogen to human monocytes. 

  15. J Clin Invest. Dejana 75 11 1985 10.1172/JCI111661 Interaction between fibrinogen and cultured endothelial cells: induction of migration and specific binding. 

  16. J Natl Cancer Inst. Dvorak 62 1459 1979 Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs: role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. 

  17. Lab Invest. Dvorak 57 673 1987 Fibrin containing gels induce angiogenesis: implications for tumor stroma generation and wound healing. 

  18. Blood. Robson 81 3006 1993 10.1182/blood.V81.11.3006.3006 Fibrin and fibrinogen degradation products with an intact D-domain C-terminal gamma chain inhibit an early step in accessory cell-dependent lymphocyte mitogenesis. 

  19. Blood. Skogen 71 1475 1988 10.1182/blood.V71.5.1475.bloodjournal7151475 Fibrinogen-derived peptide B beta 1-42 is a multidomained neutrophil chemoattractant. 

  20. Proc Natl Acad Sci U S A. Languino 92 1505 1995 10.1073/pnas.92.5.1505 Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. 

  21. J Pathol. Thompson 168 47 1992 10.1002/path.1711680109 Angiogenic activity of fibrin degradation products is located in fibrin fragment E. 

  22. Thromb Haemost. Gross 77 894 1997 10.1055/s-0038-1656074 CD11b/CD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain. 

  23. J Immunol. Plow 137 1910 1986 10.4049/jimmunol.137.6.1910 Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the A alpha chain. 

  24. Nat Med. Al-Mehdi 6 100 2000 10.1038/71429 Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. 

  25. Cancer Res. Chew 36 1904 1976 Demonstration of fibrin in early stages of experimental metastases. 

  26. Cancer Res. Crissman 48 4065 1988 Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. 

  27. Lab Invest. Crissman 53 470 1985 Arrest and extravasation of B16 amelanotic melanoma in murine lungs: a light and electron microscopic study. 

  28. Proc Natl Acad Sci U S A. Gasic 61 46 1968 10.1073/pnas.61.1.46 Antimetastatic effects associated with platelet reduction. 

  29. Science. Honn 212 1270 1981 10.1126/science.7015512 Prostacyclin: a potent antimetastatic agent. 

  30. Biochem Pharmacol. Colucci 32 1689 1983 10.1016/0006-2952(83)90110-7 Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells: role of vitamin K deficiency. 

  31. Proc Natl Acad Sci U S A. Mueller 89 11832 1992 10.1073/pnas.89.24.11832 Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. 

  32. Cancer Res. Fischer 55 1629 1995 Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells. 

  33. Genes Dev. Suh 9 2020 1995 10.1101/gad.9.16.2020 Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. 

  34. Genes Dev. Bugge 9 794 1995 10.1101/gad.9.7.794 Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. 

  35. Blood. Bugge 90 4522 1997 10.1182/blood.V90.11.4522 Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice. 

  36. Blood. Drew 91 1616 1998 10.1182/blood.V91.5.1616 Ligneous conjunctivitis in plasminogen-deficient mice. 

  37. J Natl Cancer Inst. Fidler 45 773 1970 Metastasis: guantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2'-deoxyuridine. 

  38. Cancer Chemother Rep. Geran 3 1 1972 Protocols for screening chemical agents and natural products against animal tumors and other biological systems. 

  39. EMBO J. Holmback 15 5760 1996 10.1002/j.1460-2075.1996.tb00962.x Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3. 

  40. J Biol Chem. Katagiri 270 1785 1995 10.1074/jbc.270.4.1785 Involvement of alpha v beta 3 integrin in mediating fibrin gel retraction. 

  41. J Biol Chem. Suehiro 272 5360 1997 10.1074/jbc.272.8.5360 Fibrinogen is a ligand for integrin alpha5beta1 on endothelial cells. 

  42. J Biol Chem. Ugarova 273 22519 1998 10.1074/jbc.273.35.22519 Identification of a novel recognition sequence for integrin alphaM beta2 within the gamma-chain of fibrinogen. 

  43. Biochemistry. Farrell 36 1123 1997 10.1021/bi962446r Human fibroblast adhesion to fibrinogen. 

  44. J Exp Med. Engvall 147 1584 1978 10.1084/jem.147.6.1584 Affinity of fibronectin to collagens of different genetic types and to fibrinogen. 

  45. Blood. Greenberg 66 1028 1985 10.1182/blood.V66.5.1028.1028 Regulation of plasma factor XIII binding to fibrin in vitro. 

  46. J Clin Invest. Hodivala-Dilke 103 229 1999 10.1172/JCI5487 Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. 

  47. Nature. Connolly 381 516 1996 10.1038/381516a0 Role of the thrombin receptor in development and evidence for a second receptor. 

  48. Nature. Kahn 394 690 1998 10.1038/29325 A dual thrombin receptor system for platelet activation. 

  49. J Clin Invest. Kahn 103 879 1999 10.1172/JCI6042 Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. 

  50. Proc Natl Acad Sci U S A. Ware 97 2803 2000 10.1073/pnas.050582097 Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. 

  51. Nature. Offermanns 389 183 1997 10.1038/38284 Defective platelet activation in G alpha(q)-deficient mice. 

  52. Cell. Bugge 87 709 1996 10.1016/S0092-8674(00)81390-2 Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. 

  53. Proc Natl Acad Sci U S A. Bezerra 96 15143 1999 10.1073/pnas.96.26.15143 Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver. 

  54. Proc Natl Acad Sci U S A. Sun 95 7597 1998 10.1073/pnas.95.13.7597 Prothrombin deficiency results in embryonic and neonatal lethality in mice. 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로